Alan MacKayManaging Partner at GHO Capital
Alan is a Managing Partner at GHO Capital and currently serves on the boards of GHO Portfolio Companies Alcaliber (Spain), Linimed (Germany) and Sterling Pharma (UK). He also served on the Board of GHO’s recently exited Portfolio Company, Quotient Sciences (UK / US). Alan has been a private equity investor for 30 years in roles including Senior Partner and Global Head of Healthcare at the private equity firm 3i where he was appointed to the board of 3i plc in 1993. Alan has served on the boards of global healthcare companies including Phibro Animal Health Corporation, and global private equity investors including Hermes GPE. Alan holds a Bachelor's degree in Law, an MSc in Enterprise and is a graduate of the Advanced Management Programme at INSEAD. He was Chair of the BVCA for 2016 – 2017 and has chaired its Responsible Investment Advisory Board.